T. Kissel, Y. Li, and F. Unger, ABA-triblock copolymers from biodegradable polyester A- 494 blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming 495 hydrogel delivery systems for proteins, Advanced drug delivery reviews, pp.54-99, 2002.

A. V. Kabanov, E. V. Batrakova, and D. W. Miller, Pluronic block copolymers as modulators of 497 drug efflux transporter activity in the blood-brain barrier, Adv. Drug Deliv. Rev, vol.498, pp.55-151, 2003.

A. V. Kabanov, J. Zhu, and V. Alakhov, Pluronic Block Copolymers for Gene Delivery
DOI : 10.1016/S0065-2660(05)53009-8

, Genet, vol.53, pp.231-261, 2005.

M. L. Adams, A. Lavasanifar, and G. S. Kwon, Amphiphilic block copolymers for drug 502 delivery, J Pharm Sci, pp.92-1343, 2003.

G. S. Kwon, Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds, Critical Reviews in Therapeutic Drug Carrier Systems, vol.20, issue.5, p.504
DOI : 10.1615/CritRevTherDrugCarrierSyst.v20.i5.20

, Ther Drug Carrier Syst, pp.357-403, 2003.

S. H. Kwon, S. Y. Kim, K. W. Ha, M. J. Kang, J. S. Huh et al., , p.506

K. H. Kang, S. Lee, J. Y. Chang, J. Lee, and Y. W. Choi, Pharmaceutical evaluation of genistein- 507 loaded pluronic micelles for oral delivery, Arch. Pharm. Res, pp.30-1138, 2007.

S. Danson, D. Ferry, V. Alakhov, J. Margison, D. Kerr et al.,

M. Halbert, Ranson, Phase I dose escalation and pharmacokinetic study of pluronic polymer- 510 bound doxorubicin (SP1049C) in patients with advanced cancer, Br J Cancer, pp.90-2085, 2004.

M. J. Newman, J. K. Actor, M. Balusubramanian, and C. Jagannath, Use of Nonionic Block Copolymers in Vaccines and Therapeutics, Critical Reviews?? in Therapeutic Drug Carrier Systems, vol.15, issue.2, pp.89-514, 1998.
DOI : 10.1615/CritRevTherDrugCarrierSyst.v15.i2.10

L. Desigaux, C. Gourden, M. Bello-roufai, P. Richard, N. Oudrhiri et al., , p.516

H. Pollard and B. Pitard, Nonionic amphiphilic block copolymers promote gene transfer to the 517 lung, Hum Gene Ther, vol.16, pp.821-829, 2005.

]. P. Richard, F. Bossard, L. Desigaux, C. Lanctin, M. Bello-roufai et al., Amphiphilic 519 block copolymers promote gene delivery in vivo to pathological skeletal muscles, p.518

, Ther, vol.16, pp.1318-1324, 2005.

]. D. Mcilroy, B. Barteau, J. Cany, P. Richard, C. Gourden et al., , pp.521-522

, Ther, vol.17, pp.1473-1481, 2009.

, -oxazolines) in biological and biomedical application 525 contexts, Advanced drug delivery reviews, pp.524-1504, 2007.

R. Sokolski, R. Luxenhofer, A. V. Jordan, P. Kabanov, and A. Jordan, -oxazoline) block copolymer based 528 formulations of taxanes: effect of copolymer and drug structure, concentration, and 529 environmental factors, Polym. Adv. Technol, vol.26, issue.530, pp.837-850, 2015.

. Kabanov, Structure-property relationship in cytotoxicity and cell uptake of poly

. Amphiphiles, Journal of controlled release : official journal of the Controlled Release Society, vol.533, pp.153-73, 2011.

]. R. Luxenhofer, A. Schulz, C. Roques, S. Li, T. K. Bronich et al., -oxazoline)s as high-capacity delivery systems for 536 hydrophobic drugs, 535 A.V. Kabanov, Doubly amphiphilic poly, pp.534-565, 2010.

A. Schulz, S. Jaksch, R. Schubel, E. Wegener, Z. Di et al., Drug-induced morphology switch 539 in drug delivery systems based on poly(2-oxazoline)s, ACS nano, vol.817, issue.540, pp.2686-2696, 2014.

H. Montgomery, Z. Yuan, D. Li, M. Alakhova, D. B. Sokolsky et al., , p.542

R. Luxenhofer and A. V. Kabanov, A high capacity polymeric micelle of paclitaxel: Implication 543 of high dose drug therapy to safety and in vivo anti-cancer activity, Biomaterials, vol.544, pp.101-296, 2016.

]. S. Jaksch, A. Schulz, Z. Di, R. Luxenhofer, R. Jordan et al., , p.545

, -oxazoline) with Different Hydrophobic Blocks: Changes of 547 the Micellar Structures upon Addition of a Strongly Hydrophobic Cancer Drug 548, Triblock Copolymers from Poly

, Macromolecular Chemistry and Physics, vol.217, pp.1448-1456, 2016.

]. K. Eskow-jaunarajs, D. G. Standaert, T. X. Viegas, and M. D. Bentley, Z. Fang, B. Dizman, p.549

]. B. Rasolonjatovo, J. P. Gomez, W. Meme, C. Goncalves, C. Huin et al., Movement disorders : official journal of the Movement Disorder 553 Society-methyl-2- 556 oxazoline)-b-poly(tetrahydrofuran)-b-poly(2-methyl-2-oxazoline) amphiphilic triblock 557 copolymers: synthesis, physicochemical characterizations, and hydrosolubilizing properties, Moreadith, Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained 552 antiparkinsonian benefit, pp.28-2013, 2015.

N. Autoimmune and . Diseases, The international journal of biochemistry & cell biology, pp.41-81, 2009.

P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, Bioavailability of 564 curcumin: problems and promises Curcumin use in pulmonary diseases, Mol. Pharmaceutics, vol.4, issue.565, pp.563-807, 2007.

, J.R. Riordan, J.M. Rommens, B. Kerem, N. Alon, R. Rozmahel, Z. Grzelczak, J, vol.11524, issue.567, pp.133-148, 2017.

S. Zielenski, N. Lok, J. L. Plavsic, and . Chou, Identification of the cystic fibrosis gene: 569 cloning and characterization of complementary DNA Degradation of CFTR by the ubiquitin-proteasome 571 pathway, Science Cell, vol.570, issue.572, pp.245-1066, 1989.

, Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl-channel 574 activity, J Biol Chem, vol.280, pp.5221-5226, 2005.

M. E. Egan, M. Pearson, S. A. Weiner, V. Rajendran, D. Rubin et al., , p.576

K. Canny, G. L. Du, M. J. Lukacs, B. R. Caplan, S. E. Grubb et al., Curcumin, a major constituent of turmeric, corrects 577 cystic fibrosis defects, Science Am. J. Respir. Cell Mol, vol.57828, issue.579, pp.304-600, 2004.

, Biol, vol.34, pp.355-363, 2006.

]. E. Bruscia, F. Sangiuolo, P. Sinibaldi, K. K. Goncz, G. Novelli et al., Isolation 583 of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting, Gene Ther, pp.582-584, 2002.

K. Kunzelmann, E. M. Schwiebert, P. L. Zeitlin, W. L. Kuo, B. A. Stanton et al., , p.586

A. L. Cozens, M. J. Yezzi, K. Kunzelmann, T. Ohrui, L. Chin et al., CFTR expression and chloride secretion in polarized 590 immortal human bronchial epithelial cells, An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 587 CFTR mutation Vandecasteele, C. Giaume, L. Venance, Electrical coupling between 592 hippocampal astrocytes in rat brain slices, pp.522-529, 1993.

L. Farley, G. Hjelte, M. Mclachlan, G. M. Stern, and . Roomans, Measurement of halide efflux 595 from cultured and primary airway epithelial cells using fluorescence indicators, p.596

, cystic fibrosis : official journal of the European Cystic Fibrosis Society, vol.3, issue.597, pp.171-176, 2004.

G. Pereira, C. Huin, S. Morariu, V. Bennevault-celton, and P. Guégan, Synthesis of Poly(2- 599 methyl-2-oxazoline) Star Polymers with a b-Cyclodextrin Core, Aust. J. Chem, vol.600, pp.65-1145, 2012.

]. A. Gilbert, M. Jadot, E. Leontieva, S. Wattiaux-de-coninck, and R. Wattiaux, Delta F508 602 CFTR localizes in the endoplasmic reticulum-Golgi intermediate compartment in cystic 603 fibrosis cells, Exp Cell Res, pp.601-242, 1998.

M. L. Guerra, E. M. Wauson, K. Mcglynn, and M. H. Cobb, Muscarinic control of MIN6 605 pancreatic beta cells is enhanced by impaired amino acid signaling, J Biol Chem, vol.606, pp.289-14370, 2014.

]. N. Kalin, A. Claass, M. Sommer, E. Puchelle, and B. Tummler, DeltaF508 CFTR protein 608 expression in tissues from patients with cystic fibrosis, The Journal of clinical investigation, pp.607-609, 1999.

E. Caci, A. Caputo, A. Hinzpeter, N. Arous, P. Fanen et al., , p.611

O. Ravazzolo, L. J. Zegarra-moran, C. Galietta, N. D. Muanprasat, D. Sonawane et al., Evidence for direct CFTR inhibition by 612 CFTR(inh)-172 based on Arg347 mutagenesis Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure- 615 activity analysis, and in vivo efficacy, The Journal of general physiology, Biochem J, vol.413, issue.137, pp.135-142, 2004.

. Guggino, CFTR regulates outwardly rectifying chloride channels through an autocrine 619 mechanism involving ATP, Cell, pp.81-1063, 1995.

J. J. Wine, W. E. Finkbeiner, C. Haws, M. E. Krouse, S. Moon et al., The Japanese journal of physiology, Xia, 621 CFTR and other Cl-channels in human airway cells, p.44

J. Zeng, N. Yang, X. M. Li, P. J. Shami, and J. Zhan, , p.624

. Beauveria-bassiana, Nat Prod Commun, vol.5, issue.625, pp.77-80, 2010.

Z. Stout, S. Liu, U. Mishra, R. Narain, K. Mishra et al., A novel solubility-enhanced curcumin formulation showing stability and 627 maintenance of anticancer activity Design, development and synthesis of mixed 629 bioconjugates of piperic acid-glycine, curcumin-glycine/alanine and curcumin-glycine-piperic 630 acid and their antibacterial and antifungal properties Modification of 633 curcumin with polyethylene glycol enhances the delivery of curcumin in preadipocytes and its 634 antiadipogenic property, J Pharm Sci Bioorg Med Chem J Agric Food Chem, vol.100, issue.13, pp.2778-2789, 2005.

M. K. Pandey, S. Kumar, R. K. Thimmulappa, V. S. Parmar, S. Biswal et al., , p.636

S. S. Bansal, M. Goel, F. Aqil, M. V. Vadhanam, and R. C. Gupta, Advanced drug delivery 639 systems of curcumin for cancer chemoprevention, PEGylated curcumin analogs as potent Nrf2 637 activators in human bronchial epithelial cells Curcumin nanoformulations: a future 642 nanomedicine for cancer, pp.16-24, 2011.

M. M. Yallapu, M. Jaggi, and S. C. Chauhan, Poly(beta-cyclodextrin)/curcumin self-assembly: 644 a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer 645 cells, Macromol Biosci, pp.10-1141, 2010.

]. S. Mourtas, M. Canovi, C. Zona, D. Aurilia, A. Niarakis et al.,

M. Nicotra, S. G. Gobbi, D. Antimisiaris, M. S. Wang, K. Veena et al., Liposome encapsulation of 650 curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout 651 mice Liposome-encapsulated curcumin suppresses growth 654 of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of 655 nuclear factor kappaB by an AKT-independent pathway, Biomaterials Int J Cancer Clin Cancer Res, vol.649, issue.14, pp.32-1635, 2008.

. Huang, Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded 659

, butyl cyanoacrylate) nanoparticles, Int J Pharm, vol.400, pp.211-220, 2010.

R. Mulik, K. Mahadik, and A. Paradkar, Development of curcuminoids loaded poly, p.661

, cyanoacrylate nanoparticles: Physicochemical characterization and stability study, p.662

, Pharm Sci, vol.37, pp.395-404, 2009.

M. M. Yallapu, B. K. Gupta, M. Jaggi, and S. C. Chauhan, Fabrication of curcumin 664 encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells, J Colloid Interface Sci, vol.665, pp.351-370, 2010.

Z. Yang, N. Li, L. Wang, L. Li, T. Song et al., 667 C. Gong, Curcumin-encapsulated polymeric micelles suppress the development of colon 668 cancer in vitro and in vivo, Scientific reports, p.666

, Pharm, vol.7, pp.86-93, 2010.

]. K. Knop, R. Hoogenboom, D. Fischer, and U. S. Schubert, Poly(ethylene glycol) in drug 673 delivery: pros and cons as well as potential alternatives, Angewandte Chemie, vol.674, pp.672-721, 2010.

T. X. Viegas, M. D. Bentley, J. M. Harris, Z. Fang, K. Yoon et al., , p.675

G. Mero, F. M. Pasut, and . Veronese, Polyoxazoline: chemistry, properties, and applications in 677 drug delivery, Bioconjugate chemistry, vol.22, issue.678, pp.976-986, 2011.

. Guegan, Evidence of DNA transfer across a model membrane by a neutral amphiphilic block 680 copolymer, J Gene Med, vol.13, pp.538-548, 2011.

]. T. Okiyoneda, A. Niibori, K. Harada, T. Kohno, M. Michalak et al., , p.681

T. Ikawa, M. A. Shuto, H. Suico, and . Kai, Role of calnexin in the ER quality control and 683 productive folding of CFTR, p.684

C. Deltaf508, Biochim Biophys Acta, pp.1783-1585, 2008.

S. Kamhi-nesher, M. Shenkman, S. Tolchinsky, S. V. Fromm, R. Ehrlich et al., , p.686

. Lederkremer, A novel quality control compartment derived from the endoplasmic reticulum, p.687

, Mol Biol Cell, vol.12, pp.1711-1723, 2001.

J. Butler, H. R. Watson, A. G. Lee, H. J. Schuppe, and J. M. East, Retrieval from the ER-golgi 689 intermediate compartment is key to the targeting of c-terminally anchored ER-resident 690 proteins, J Cell Biochem, vol.11264, issue.691, pp.3543-3548, 2011.

, Revisiting CFTR inhibition: a comparative study of CFTRinh -172 and GlyH-101 inhibitors, 693, British journal of pharmacology, vol.171, pp.3716-3727, 2014.

J. G. Bilmen, S. Z. Khan, M. H. Javed, and F. Michelangeli, Inhibition of the SERCA Ca2+ 695 pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide- 696 binding and phosphorylation domains in the absence of ATP, Eur J Biochem, vol.697, pp.268-6318, 2001.

M. J. Logan-smith, P. J. Lockyer, J. M. East, and A. G. Lee, , p.699

, the Ca2+-ATPase of sarcoplasmic reticulum but increases the rate of accumulation of Ca2+, p.700

, Biol Chem, vol.276, issue.701, pp.46905-46911, 2001.

, Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha- 703 glucosidase inhibitor miglustat, FEBS Lett, vol.580, p.705, 2006.

M. A. Schrattenholz, A. Cahill, and . Edelman, , p.706

, keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator 707 (CFTR)/deltaF508-CFTR to the plasma membrane The international journal of biochemistry & cell 709 biology, Proteomics Cytoskeleton and CFTR, issue.4, pp.52-68, 2004.

J. Lipecka, C. Norez, N. Bensalem, M. Baudouin-legros, and G. ,

N. Edelman and . Davezac, Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane 712 conductance regulator) by curcumin: involvement of the keratin 18 network, J Pharmacol Exp, p.713

, Ther, pp.317-500, 2006.

J. B. , Baell, Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan, p.715

, Assay Interference Compounds (PAINS) Journal of natural products, vol.79, pp.616-628, 2016.

, Figure 1: (A) Chemical structure of the amphiphilic triblock copolymer MeOx 6 -THF, pp.19-725

, (B) Cur solubilisation in a TBCP2 aqueous solution. Two mg Cur was 726 added to 5 ml of a 0, MeOx 6 (TBCP2)2% TBCP2 solution in water (+TBCP2) or in 5 ml water, p.727

, H 1 NMR spectrum of TBCP2. (D) Size of TBCP2 micelles and Cur/TBCP2 formulation